Reduction in fatigue · chronic pain in MS
1 finding from 1 review
Reduction in depression · chronic pain in MS
1 finding from 1 review
Reduction in Spasms · chronic pain in MS
1 finding from 1 review
Quality of life · chronic back pain in MS
1 finding from 1 review
Reduction in pain intensity · chronic musculoskeletal pain in people with MS
1 finding from 1 review
Reduction in disability · chronic musculoskeletal pain in people with MS
1 finding from 1 review
Quality of life · chronic musculoskeletal pain in people with MS
1 finding from 1 review
Reduction in fatigue · chronic musculoskeletal pain in people with MS
1 finding from 1 review
Reduction in pain intensity · chronic neuropathic pain in MS
1 finding from 1 review
Reduction in fatigue · chronic neuropathic pain in MS
1 finding from 1 review
Attachment change · Adult patients with single (localised) recession-type defects (Miller Class I/II, at least 3 mm)
ADMG + CAF showed no clear difference in clinical attachment level change compared with SCTG + CAF (low certainty).
1 finding from 1 review
Attachment change · Adult patients with single (localised) recession-type defects (Miller Class I/II, at least 3 mm)
EMP + CAF showed no clear difference in clinical attachment level change compared with CAF (low certainty).
2 findings from 1 review
Occurrence of adverse effects or postoperative complications · Adult patients with single (localised) recession-type defects (Miller Class I/II, at least 3 mm)
1 finding from 1 review
Sites with complete root coverage · Adult patients with single (localised) recession-type defects (Miller Class I/II, at least 3 mm)
ADMG + CAF showed no clear difference in sites with complete root coverage compared with SCTG + CAF (low certainty).
1 finding from 1 review
Keratinized tissue change · Adult patients with single (localised) recession-type defects (Miller Class I/II, at least 3 mm)
It is very uncertain whether EMP + CAF changes keratinized tissue change compared with SCTG + CAF (very low certainty).
1 finding from 1 review
Keratinized tissue width change · Adult patients with single (localised) recession-type defects (Miller Class I/II, at least 3 mm)
GTR rm associated with bone substitutes + CAF led to lower keratinized tissue width change compared with SCTG + CAF; GRADE not reported.
1 finding from 1 review
MD -2.38 [-2.84, -1.92]
2 studies
GRADE not reported
Patients' preference for a specific procedure · Adult patients with single (localised) recession-type defects (Miller Class I/II, at least 3 mm)
1 finding from 1 review
Aesthetic condition change related to patient's opinion · Adult patients with single (localised) recession-type defects (Miller Class I/II, at least 3 mm)
The review found no eligible studies for this question.
1 finding from 1 review
Aesthetic condition change related to patient's opinion · Adult patients with single (localised) recession-type defects (Miller Class I/II, at least 3 mm)
1 finding from 1 review
Occurrence of adverse effects or postoperative complications · Adult patients with single (localised) recession-type defects (Miller Class I/II, at least 3 mm)
1 finding from 1 review